Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

FENNEC PHARMACEUTICALS INC. (FENC)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14
   10-K10-K10-K10-K10-K10-K10-K10-K
Revenues   [+]0.00.20.00.00.00.00.00.3
            Revenue growth  -100.0%     -100.0% 
Cost of goods sold  0.00.00.00.00.00.00.00.3
Gross profit  0.00.20.00.00.00.00.00.0
            Gross margin   100.0%     0.0%
Selling, general and administrative   [+]12.213.07.45.45.02.41.62.5
Research and development  5.05.15.65.01.90.50.30.4
EBITDA   [+]        
Depreciation and amortization          
EBIT   [+]-17.2-17.9-13.0-10.4-7.0-2.9-1.9-2.9
            EBIT margin   -10520.6%     -824.4%
Interest income  0.10.10.30.30.00.00.00.0
Other income (expense), net   [+]-0.2-0.3-0.10.2-0.10.11.20.7
Pre-tax income  -17.3-18.1-12.8-9.9-7.0-2.8-0.7-2.2
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -17.3-18.1-12.8-9.9-7.0-2.8-0.7-2.2
            Net margin   -10652.4%     -623.5%
   
Basic EPS   [+]($0.67)($0.76)($0.64)($0.52)($0.47)($0.22)($0.06)($0.22)
Diluted EPS   [+]($0.67)($0.76)($0.64)($0.52)($0.47)($0.22)($0.06)($0.22)
   
Shares outstanding (basic)   [+]26.023.719.918.915.012.810.89.9
Shares outstanding (diluted)   [+]26.023.719.918.915.012.810.89.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy